The majority of the vials for Pfizer/BioNTech’s coronavirus vaccine will be produced at Schott Hungary in Lukácsháza, western Hungary, Foreign Minister Péter Szijjártó said on Friday.
Schott Hungary has invested 13.5 billion forints (EUR 37.6m) to set up the 16 production lines to manufacture the ampules, Szijjártó said. The government is supporting the investment with a 2 billion grant, he added.
The Lukácsháza plant is Schott’s largest ampule production facility in the world, and employs 550 people.
Richter Gedeon Nyrt. CEO Gábor Orbán talked about the rapid development and production of the promising coronavirus medication and the relationship between the pandemic and the pharmaceutical industry in an interview given to Inforádió. To go from an existing recipe to producing remdesivir, Richter took a record five months instead of the more common twelve, […]Continue reading
Schott’s decision to bring this investment to Hungary further strengthens German-Hungarian economic ties, Szijjártó said. Currently 6,000 German companies employ some 300,000 people in Hungary, he added.
Featured photo by MTI/Biontech SE/EPA